AustralieFrV1, PubMed, Checkpoint, bibRecord, 000307

Symptomatic Patients Remain at Substantial Risk of Arterial Disease Complications Before and After Endarterectomy or Stenting.

Identifieur interne : 000307 ( PubMed/Checkpoint ); précédent : 000306; suivant : 000308

Symptomatic Patients Remain at Substantial Risk of Arterial Disease Complications Before and After Endarterectomy or Stenting.

Auteurs : Cristina Hobeanu ; Philippa C. Lavallée ; Peter M. Rothwell ; Leila Sissani ; Gregory W. Albers ; Natan M. Bornstein ; Louis R. Caplan ; Geoffrey A. Donnan ; José M. Ferro ; Michael G. Hennerici ; Julien Labreuche ; Carlos Molina ; Philippe Gabriel Steg ; Pierre-Jean Touboul ; Shinichiro Uchiyama ; Éric Vicaut ; Lawrence K S. Wong ; Pierre Amarenco [France]

Source :

Stroke [ 1524-4628 ] ; 2017.

RBID : pubmed:28289241

Descripteurs français

English descriptors

KwdEn :
- Aged, Aged, 80 and over, Carotid Stenosis (surgery), Case-Control Studies, Endarterectomy, Carotid (adverse effects), Endarterectomy, Carotid (methods), Endarterectomy, Carotid (statistics & numerical data), Female, Follow-Up Studies, Humans, Ischemic Attack, Transient (epidemiology), Ischemic Attack, Transient (etiology), Male, Middle Aged, Myocardial Infarction (epidemiology), Myocardial Infarction (etiology), Outcome Assessment (Health Care) (statistics & numerical data), Registries (statistics & numerical data), Stents, Stroke (epidemiology), Stroke (etiology), Vascular Surgical Procedures (adverse effects), Vascular Surgical Procedures (methods), Vascular Surgical Procedures (statistics & numerical data).
MESH :
- adverse effects : Endarterectomy, Carotid, Vascular Surgical Procedures.
- epidemiology : Ischemic Attack, Transient, Myocardial Infarction, Stroke.
- etiology : Ischemic Attack, Transient, Myocardial Infarction, Stroke.
- methods : Endarterectomy, Carotid, Vascular Surgical Procedures.
- statistics & numerical data : Endarterectomy, Carotid, Outcome Assessment (Health Care), Registries, Vascular Surgical Procedures.
- surgery : Carotid Stenosis.
- Aged, Aged, 80 and over, Case-Control Studies, Female, Follow-Up Studies, Humans, Male, Middle Aged, Stents.

Abstract

After carotid endarterectomy (CEA) or carotid artery stenting (CAS) in patients with transient ischemic attack or minor ischemic stroke, recurrent stroke risk falls to a low rate on modern medical treatment.

DOI: 10.1161/STROKEAHA.116.015171
PubMed: 28289241

Affiliations:

France

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 000E56
to stream PubMed, to step Curation: 000E53

Links to Exploration step

pubmed:28289241

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Symptomatic Patients Remain at Substantial Risk of Arterial Disease Complications Before and After Endarterectomy or Stenting.</title>
<author><name sortKey="Hobeanu, Cristina" sort="Hobeanu, Cristina" uniqKey="Hobeanu C" first="Cristina" last="Hobeanu">Cristina Hobeanu</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Lavallee, Philippa C" sort="Lavallee, Philippa C" uniqKey="Lavallee P" first="Philippa C" last="Lavallée">Philippa C. Lavallée</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Rothwell, Peter M" sort="Rothwell, Peter M" uniqKey="Rothwell P" first="Peter M" last="Rothwell">Peter M. Rothwell</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Sissani, Leila" sort="Sissani, Leila" uniqKey="Sissani L" first="Leila" last="Sissani">Leila Sissani</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Albers, Gregory W" sort="Albers, Gregory W" uniqKey="Albers G" first="Gregory W" last="Albers">Gregory W. Albers</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Bornstein, Natan M" sort="Bornstein, Natan M" uniqKey="Bornstein N" first="Natan M" last="Bornstein">Natan M. Bornstein</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Caplan, Louis R" sort="Caplan, Louis R" uniqKey="Caplan L" first="Louis R" last="Caplan">Louis R. Caplan</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Donnan, Geoffrey A" sort="Donnan, Geoffrey A" uniqKey="Donnan G" first="Geoffrey A" last="Donnan">Geoffrey A. Donnan</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Ferro, Jose M" sort="Ferro, Jose M" uniqKey="Ferro J" first="José M" last="Ferro">José M. Ferro</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Hennerici, Michael G" sort="Hennerici, Michael G" uniqKey="Hennerici M" first="Michael G" last="Hennerici">Michael G. Hennerici</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Labreuche, Julien" sort="Labreuche, Julien" uniqKey="Labreuche J" first="Julien" last="Labreuche">Julien Labreuche</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Molina, Carlos" sort="Molina, Carlos" uniqKey="Molina C" first="Carlos" last="Molina">Carlos Molina</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Steg, Philippe Gabriel" sort="Steg, Philippe Gabriel" uniqKey="Steg P" first="Philippe Gabriel" last="Steg">Philippe Gabriel Steg</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Touboul, Pierre Jean" sort="Touboul, Pierre Jean" uniqKey="Touboul P" first="Pierre-Jean" last="Touboul">Pierre-Jean Touboul</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Uchiyama, Shinichiro" sort="Uchiyama, Shinichiro" uniqKey="Uchiyama S" first="Shinichiro" last="Uchiyama">Shinichiro Uchiyama</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Vicaut, Eric" sort="Vicaut, Eric" uniqKey="Vicaut E" first="Éric" last="Vicaut">Éric Vicaut</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Wong, Lawrence K S" sort="Wong, Lawrence K S" uniqKey="Wong L" first="Lawrence K S" last="Wong">Lawrence K S. Wong</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Amarenco, Pierre" sort="Amarenco, Pierre" uniqKey="Amarenco P" first="Pierre" last="Amarenco">Pierre Amarenco</name>
<affiliation wicri:level="1"><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.). pierre.amarenco@aphp.fr.</nlm:affiliation>
<country wicri:rule="url">France</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28289241</idno>
<idno type="pmid">28289241</idno>
<idno type="doi">10.1161/STROKEAHA.116.015171</idno>
<idno type="wicri:Area/PubMed/Corpus">000E56</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000E56</idno>
<idno type="wicri:Area/PubMed/Curation">000E53</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000E53</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000E53</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000E53</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Symptomatic Patients Remain at Substantial Risk of Arterial Disease Complications Before and After Endarterectomy or Stenting.</title>
<author><name sortKey="Hobeanu, Cristina" sort="Hobeanu, Cristina" uniqKey="Hobeanu C" first="Cristina" last="Hobeanu">Cristina Hobeanu</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Lavallee, Philippa C" sort="Lavallee, Philippa C" uniqKey="Lavallee P" first="Philippa C" last="Lavallée">Philippa C. Lavallée</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Rothwell, Peter M" sort="Rothwell, Peter M" uniqKey="Rothwell P" first="Peter M" last="Rothwell">Peter M. Rothwell</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Sissani, Leila" sort="Sissani, Leila" uniqKey="Sissani L" first="Leila" last="Sissani">Leila Sissani</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Albers, Gregory W" sort="Albers, Gregory W" uniqKey="Albers G" first="Gregory W" last="Albers">Gregory W. Albers</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Bornstein, Natan M" sort="Bornstein, Natan M" uniqKey="Bornstein N" first="Natan M" last="Bornstein">Natan M. Bornstein</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Caplan, Louis R" sort="Caplan, Louis R" uniqKey="Caplan L" first="Louis R" last="Caplan">Louis R. Caplan</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Donnan, Geoffrey A" sort="Donnan, Geoffrey A" uniqKey="Donnan G" first="Geoffrey A" last="Donnan">Geoffrey A. Donnan</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Ferro, Jose M" sort="Ferro, Jose M" uniqKey="Ferro J" first="José M" last="Ferro">José M. Ferro</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Hennerici, Michael G" sort="Hennerici, Michael G" uniqKey="Hennerici M" first="Michael G" last="Hennerici">Michael G. Hennerici</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Labreuche, Julien" sort="Labreuche, Julien" uniqKey="Labreuche J" first="Julien" last="Labreuche">Julien Labreuche</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Molina, Carlos" sort="Molina, Carlos" uniqKey="Molina C" first="Carlos" last="Molina">Carlos Molina</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Steg, Philippe Gabriel" sort="Steg, Philippe Gabriel" uniqKey="Steg P" first="Philippe Gabriel" last="Steg">Philippe Gabriel Steg</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Touboul, Pierre Jean" sort="Touboul, Pierre Jean" uniqKey="Touboul P" first="Pierre-Jean" last="Touboul">Pierre-Jean Touboul</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Uchiyama, Shinichiro" sort="Uchiyama, Shinichiro" uniqKey="Uchiyama S" first="Shinichiro" last="Uchiyama">Shinichiro Uchiyama</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Vicaut, Eric" sort="Vicaut, Eric" uniqKey="Vicaut E" first="Éric" last="Vicaut">Éric Vicaut</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Wong, Lawrence K S" sort="Wong, Lawrence K S" uniqKey="Wong L" first="Lawrence K S" last="Wong">Lawrence K S. Wong</name>
<affiliation><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</nlm:affiliation>
<wicri:noCountry code="subField">Hong Kong SAR (K.S.L.W.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Amarenco, Pierre" sort="Amarenco, Pierre" uniqKey="Amarenco P" first="Pierre" last="Amarenco">Pierre Amarenco</name>
<affiliation wicri:level="1"><nlm:affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.). pierre.amarenco@aphp.fr.</nlm:affiliation>
<country wicri:rule="url">France</country>
</affiliation>
</author>
</analytic>
<series><title level="j">Stroke</title>
<idno type="eISSN">1524-4628</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Carotid Stenosis (surgery)</term>
<term>Case-Control Studies</term>
<term>Endarterectomy, Carotid (adverse effects)</term>
<term>Endarterectomy, Carotid (methods)</term>
<term>Endarterectomy, Carotid (statistics & numerical data)</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Ischemic Attack, Transient (epidemiology)</term>
<term>Ischemic Attack, Transient (etiology)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Myocardial Infarction (epidemiology)</term>
<term>Myocardial Infarction (etiology)</term>
<term>Outcome Assessment (Health Care) (statistics & numerical data)</term>
<term>Registries (statistics & numerical data)</term>
<term>Stents</term>
<term>Stroke (epidemiology)</term>
<term>Stroke (etiology)</term>
<term>Vascular Surgical Procedures (adverse effects)</term>
<term>Vascular Surgical Procedures (methods)</term>
<term>Vascular Surgical Procedures (statistics & numerical data)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Accident ischémique transitoire (épidémiologie)</term>
<term>Accident ischémique transitoire (étiologie)</term>
<term>Accident vasculaire cérébral (épidémiologie)</term>
<term>Accident vasculaire cérébral (étiologie)</term>
<term>Adulte d'âge moyen</term>
<term>Endartériectomie carotidienne ()</term>
<term>Endartériectomie carotidienne (effets indésirables)</term>
<term>Endoprothèses</term>
<term>Enregistrements ()</term>
<term>Femelle</term>
<term>Humains</term>
<term>Infarctus du myocarde (épidémiologie)</term>
<term>Infarctus du myocarde (étiologie)</term>
<term>Mâle</term>
<term>Procédures de chirurgie vasculaire ()</term>
<term>Procédures de chirurgie vasculaire (effets indésirables)</term>
<term>Sténose carotidienne ()</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Études cas-témoins</term>
<term>Études de suivi</term>
<term>Évaluation de résultat (soins) ()</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Endarterectomy, Carotid</term>
<term>Vascular Surgical Procedures</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Endartériectomie carotidienne</term>
<term>Procédures de chirurgie vasculaire</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Ischemic Attack, Transient</term>
<term>Myocardial Infarction</term>
<term>Stroke</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Ischemic Attack, Transient</term>
<term>Myocardial Infarction</term>
<term>Stroke</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Endarterectomy, Carotid</term>
<term>Vascular Surgical Procedures</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Endarterectomy, Carotid</term>
<term>Outcome Assessment (Health Care)</term>
<term>Registries</term>
<term>Vascular Surgical Procedures</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Carotid Stenosis</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Accident ischémique transitoire</term>
<term>Accident vasculaire cérébral</term>
<term>Infarctus du myocarde</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Accident ischémique transitoire</term>
<term>Accident vasculaire cérébral</term>
<term>Infarctus du myocarde</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Case-Control Studies</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Stents</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Endartériectomie carotidienne</term>
<term>Endoprothèses</term>
<term>Enregistrements</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Procédures de chirurgie vasculaire</term>
<term>Sténose carotidienne</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Études cas-témoins</term>
<term>Études de suivi</term>
<term>Évaluation de résultat (soins)</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">After carotid endarterectomy (CEA) or carotid artery stenting (CAS) in patients with transient ischemic attack or minor ischemic stroke, recurrent stroke risk falls to a low rate on modern medical treatment.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28289241</PMID>
<DateCreated><Year>2017</Year>
<Month>03</Month>
<Day>14</Day>
</DateCreated>
<DateCompleted><Year>2017</Year>
<Month>06</Month>
<Day>05</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>06</Month>
<Day>05</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1524-4628</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>48</Volume>
<Issue>4</Issue>
<PubDate><Year>2017</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>Stroke</Title>
<ISOAbbreviation>Stroke</ISOAbbreviation>
</Journal>
<ArticleTitle>Symptomatic Patients Remain at Substantial Risk of Arterial Disease Complications Before and After Endarterectomy or Stenting.</ArticleTitle>
<Pagination><MedlinePgn>1005-1010</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1161/STROKEAHA.116.015171</ELocationID>
<Abstract><AbstractText Label="BACKGROUND AND PURPOSE" NlmCategory="OBJECTIVE">After carotid endarterectomy (CEA) or carotid artery stenting (CAS) in patients with transient ischemic attack or minor ischemic stroke, recurrent stroke risk falls to a low rate on modern medical treatment.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We used data from 4583 patients with recent transient ischemic attack or minor stroke enrolled in the TIAregistry.org to perform a nested case-control analysis to evaluate pre- and post-CEA/CAS risk. Cases were defined as patients with a CEA/CAS during the 1-year follow-up period. For each case, 2 controls with a follow-up time greater than the time from qualifying event to CEA/CAS were randomly selected, matched by age and sex. Primary outcome was defined as major vascular events (MVE, including stroke, cardiovascular death, and myocardial infarction).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The median delay from symptom onset of qualifying event to CEA/CAS was 11 days (interquartile range, 6-23). Overall, patients with CEA/CAS had a higher 1-year risk of MVE than other patients (14.8% versus 5.8%; adjusted hazard ratio, 2.40; 95% confidence interval, 1.61-3.60; P<0.001). During the matched preprocedural period, MVE occurred in 14 (7.5%) cases and in 13 (3.5%) controls, with an adjusted odds ratio =2.46 (95% confidence interval, 1.07-5.64; P=0.03). In the postprocedural period, the risk of MVE was also higher in cases than in controls (adjusted P<0.03).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Patients with CEA/CAS had a higher 12-month risk of MVE, as well as during pre- and postprocedural periods. These results suggest that patients in whom CEA/CAS is anticipated are likely to be an informative population for inclusion in studies testing new antithrombotic strategies started soon after symptom onset.</AbstractText>
<CopyrightInformation>© 2017 American Heart Association, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hobeanu</LastName>
<ForeName>Cristina</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lavallée</LastName>
<ForeName>Philippa C</ForeName>
<Initials>PC</Initials>
<AffiliationInfo><Affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Rothwell</LastName>
<ForeName>Peter M</ForeName>
<Initials>PM</Initials>
<AffiliationInfo><Affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sissani</LastName>
<ForeName>Leila</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Albers</LastName>
<ForeName>Gregory W</ForeName>
<Initials>GW</Initials>
<AffiliationInfo><Affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bornstein</LastName>
<ForeName>Natan M</ForeName>
<Initials>NM</Initials>
<AffiliationInfo><Affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Caplan</LastName>
<ForeName>Louis R</ForeName>
<Initials>LR</Initials>
<AffiliationInfo><Affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Donnan</LastName>
<ForeName>Geoffrey A</ForeName>
<Initials>GA</Initials>
<AffiliationInfo><Affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ferro</LastName>
<ForeName>José M</ForeName>
<Initials>JM</Initials>
<AffiliationInfo><Affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hennerici</LastName>
<ForeName>Michael G</ForeName>
<Initials>MG</Initials>
<AffiliationInfo><Affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Labreuche</LastName>
<ForeName>Julien</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Molina</LastName>
<ForeName>Carlos</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Steg</LastName>
<ForeName>Philippe Gabriel</ForeName>
<Initials>PG</Initials>
<AffiliationInfo><Affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Touboul</LastName>
<ForeName>Pierre-Jean</ForeName>
<Initials>PJ</Initials>
<AffiliationInfo><Affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Uchiyama</LastName>
<ForeName>Shinichiro</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Vicaut</LastName>
<ForeName>Éric</ForeName>
<Initials>É</Initials>
<AffiliationInfo><Affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wong</LastName>
<ForeName>Lawrence K S</ForeName>
<Initials>LK</Initials>
<AffiliationInfo><Affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Amarenco</LastName>
<ForeName>Pierre</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>From APHP, Department of Neurology and Stroke Center, Bichat Hospital, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, France (C.H., P.C.L., L.S., J.L., P.-J.T., P.A.); Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center (G.W.A.); Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel (N.M.B.); Department of Neurosciences (Neurology), Hospital Santa Maria, University of Lisbon, Portugal (J.M.F.); Cerebrovascular Disease Service, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA (L.R.C.); The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia (G.A.D.); Department of Neurology, UMM University Heidelberg, Germany (M.G.H.); Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Spain (C.M.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, University of Oxford, UK (P.M.R.); APHP, Department of Cardiology, INSERM LVTS-U1148, DHU FIRE, Université Paris-Diderot, Sorbonne-Paris Cité, Hôpital Bichat, Paris, France; and NHLI Imperial College, ICMS Royal Brompton Hospital London, UK (P.G.S.); Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center, Tokyo, Japan (S.U.); APHP, Department of Biostatistics, Université Paris-Diderot, Sorbonne-Paris Cité, Fernand Widal hospital, Paris, France (É.V.); and Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR (K.S.L.W.). pierre.amarenco@aphp.fr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><CollectiveName>TIAregistry.org Investigators</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D064888">Observational Study</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2017</Year>
<Month>03</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Stroke</MedlineTA>
<NlmUniqueID>0235266</NlmUniqueID>
<ISSNLinking>0039-2499</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016893" MajorTopicYN="N">Carotid Stenosis</DescriptorName>
<QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016894" MajorTopicYN="N">Endarterectomy, Carotid</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002546" MajorTopicYN="N">Ischemic Attack, Transient</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment (Health Care)</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015607" MajorTopicYN="Y">Stents</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014656" MajorTopicYN="N">Vascular Surgical Procedures</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">carotid arteries</Keyword>
<Keyword MajorTopicYN="Y">carotid endarterectomy</Keyword>
<Keyword MajorTopicYN="Y">myocardial infarction</Keyword>
<Keyword MajorTopicYN="Y">prevention</Keyword>
<Keyword MajorTopicYN="Y">transient ischemic attack</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year>
<Month>08</Month>
<Day>19</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2017</Year>
<Month>12</Month>
<Day>27</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2017</Year>
<Month>01</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2017</Year>
<Month>3</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>6</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2017</Year>
<Month>3</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">28289241</ArticleId>
<ArticleId IdType="pii">STROKEAHA.116.015171</ArticleId>
<ArticleId IdType="doi">10.1161/STROKEAHA.116.015171</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>France</li>
</country>
</list>
<tree><noCountry><name sortKey="Albers, Gregory W" sort="Albers, Gregory W" uniqKey="Albers G" first="Gregory W" last="Albers">Gregory W. Albers</name>
<name sortKey="Bornstein, Natan M" sort="Bornstein, Natan M" uniqKey="Bornstein N" first="Natan M" last="Bornstein">Natan M. Bornstein</name>
<name sortKey="Caplan, Louis R" sort="Caplan, Louis R" uniqKey="Caplan L" first="Louis R" last="Caplan">Louis R. Caplan</name>
<name sortKey="Donnan, Geoffrey A" sort="Donnan, Geoffrey A" uniqKey="Donnan G" first="Geoffrey A" last="Donnan">Geoffrey A. Donnan</name>
<name sortKey="Ferro, Jose M" sort="Ferro, Jose M" uniqKey="Ferro J" first="José M" last="Ferro">José M. Ferro</name>
<name sortKey="Hennerici, Michael G" sort="Hennerici, Michael G" uniqKey="Hennerici M" first="Michael G" last="Hennerici">Michael G. Hennerici</name>
<name sortKey="Hobeanu, Cristina" sort="Hobeanu, Cristina" uniqKey="Hobeanu C" first="Cristina" last="Hobeanu">Cristina Hobeanu</name>
<name sortKey="Labreuche, Julien" sort="Labreuche, Julien" uniqKey="Labreuche J" first="Julien" last="Labreuche">Julien Labreuche</name>
<name sortKey="Lavallee, Philippa C" sort="Lavallee, Philippa C" uniqKey="Lavallee P" first="Philippa C" last="Lavallée">Philippa C. Lavallée</name>
<name sortKey="Molina, Carlos" sort="Molina, Carlos" uniqKey="Molina C" first="Carlos" last="Molina">Carlos Molina</name>
<name sortKey="Rothwell, Peter M" sort="Rothwell, Peter M" uniqKey="Rothwell P" first="Peter M" last="Rothwell">Peter M. Rothwell</name>
<name sortKey="Sissani, Leila" sort="Sissani, Leila" uniqKey="Sissani L" first="Leila" last="Sissani">Leila Sissani</name>
<name sortKey="Steg, Philippe Gabriel" sort="Steg, Philippe Gabriel" uniqKey="Steg P" first="Philippe Gabriel" last="Steg">Philippe Gabriel Steg</name>
<name sortKey="Touboul, Pierre Jean" sort="Touboul, Pierre Jean" uniqKey="Touboul P" first="Pierre-Jean" last="Touboul">Pierre-Jean Touboul</name>
<name sortKey="Uchiyama, Shinichiro" sort="Uchiyama, Shinichiro" uniqKey="Uchiyama S" first="Shinichiro" last="Uchiyama">Shinichiro Uchiyama</name>
<name sortKey="Vicaut, Eric" sort="Vicaut, Eric" uniqKey="Vicaut E" first="Éric" last="Vicaut">Éric Vicaut</name>
<name sortKey="Wong, Lawrence K S" sort="Wong, Lawrence K S" uniqKey="Wong L" first="Lawrence K S" last="Wong">Lawrence K S. Wong</name>
</noCountry>
<country name="France"><noRegion><name sortKey="Amarenco, Pierre" sort="Amarenco, Pierre" uniqKey="Amarenco P" first="Pierre" last="Amarenco">Pierre Amarenco</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000307 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000307 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:28289241
   |texte=   Symptomatic Patients Remain at Substantial Risk of Arterial Disease Complications Before and After Endarterectomy or Stenting.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:28289241" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Symptomatic Patients Remain at Substantial Risk of Arterial Disease Complications Before and After Endarterectomy or Stenting.

Symptomatic Patients Remain at Substantial Risk of Arterial Disease Complications Before and After Endarterectomy or Stenting.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki